Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on June 2, 2025
Aclaris Therapeutics Initiates Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
GlobeNewswire
·
June 2, 2025
- Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time, and Affinity to Thymic Stromal Lymphopoietin (TSLP) - - Top Line Results Expected in the Second Half of 2026 - WAYNE, Pa., June …
SAIC Announces First Quarter of Fiscal Year 2026 Results
GlobeNewswire
·
June 2, 2025
Revenues of $1.88 billion; approximately 2% revenue growth Net bookings of $2.4 billion; book-to-bill ratio of 1.3 Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues Diluted earnings per share of $1.42; Adjusted diluted …
Cancer mRNA Vaccine Clinical Trials FDA Approval mRNA Therapies Clinical Advances Insight
GlobeNewswire
·
June 2, 2025
Delhi, June 02, 2025 (GLOBE NEWSWIRE) -- mRNA cancer vaccines approach clinical maturity, the commercial landscape surrounding them is rapidly changing. Over 60 candidates in the works, with a few in Phase III clinical trials, the industry is increasingly …
Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
GlobeNewswire
·
June 2, 2025
Deucrictibant data shows single-dose durability without symptom reoccurrence in the majority of HAE attacks treated First-ever bradykinin B2 receptor mechanism-on-mechanism prophylactic/on-demand data supports potential for deucrictibant portfolio …
BioNTech und Bristol Myers Squibb geben globale strategische Partnerschaft zur gemeinsamen Entwicklung und Kommerzialisierung des bispezifischen Antikörperkandidaten BNT327 in einer Vielzahl solider Tumorarten bekannt
GlobeNewswire
·
June 2, 2025
BioNTechs bispezifischer PD-L1xVEGF-Antikörper BNT327 ist ein Immuntherapiekandidat in der fortgeschrittenen klinischen Entwicklung, der das Potenzial hat für verschiedene Tumorarten einen neuen Behandlungsstandard zu setzen, der über die traditionellen …
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types
GlobeNewswire
·
June 2, 2025
BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new standard of care in multiple tumor types The co- …
Castellum, Inc. to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Virtual Conference Presented by Maxim Group LLC on Tuesday, June 3rd – Thursday, June 5th at 9:00 a.m. EDT
GlobeNewswire
·
June 2, 2025
VIENNA, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) announces that its Chief Executive Officer, Glen Ives, has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” …
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
GlobeNewswire
·
June 2, 2025
YUTREPIA now available to be prescribed to patients via specialty pharmacies FDA approved YUTREPIA on May 23, 2025 Court denies United Therapeutics’ request for preliminary injunction and a temporary restraining order, clearing the path for full commercial …
Stomp Into Some Prehistoric Learning! Lingokids and BBC Earth Launch New Walking With Dinosaurs Lesson to Bring a Love of Dinosaurs to a New Generation
GlobeNewswire
·
June 2, 2025
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- Get ready to dig, discover, and roar with excitement. Lingokids and BBC Earth are launching an exclusive Walking with Dinosaurs Lesson in the Lingokids app just in time for Dinosaur Day and the premiere of the …
L’hébergement souverain : un impératif stratégique
GlobeNewswire
·
June 2, 2025
Le contexte géopolitique actuel est plus que jamais un signal fort sur la nécessité de repenser nos infrastructures IT et de positionner la souveraineté comme un enjeu central. En effet, au cœur de la création de valeur des entreprises, le numérique est un …
ClarityCut AI Launches to Revolutionize Video Editing with AI-Powered Simplicity
GlobeNewswire
·
June 2, 2025
SEATTLE, June 02, 2025 (GLOBE NEWSWIRE) -- CLEANZONE HVAC LLC proudly announces the official launch of ClarityCut AI, a cutting-edge video editing platform designed to empower creators through the speed and precision of artificial intelligence. The …
Conscio Technologies lance une offre de sensibilisation à la cybersécurité dédiée aux professionnels de l’assurance
GlobeNewswire
·
June 2, 2025
Conscio Technologies, spécialiste de la sensibilisation à la cybersécurité, annonce la création d’une offre dédiée aux acteurs de l’assurance et notamment la mise à disposition d’un contenu spécifique sur la réglementation DORA. Le secteur des assurances …
Xilio Therapeutics Announces Proposed Public Offering
GlobeNewswire
·
June 2, 2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that it is …
IA génératives : reprendre la main, la vision de SASETY pour les entreprises
GlobeNewswire
·
June 2, 2025
Par Jérôme Beaufils, CEO de SASETY Introduction Les intelligences artificielles génératives transforment rapidement les usages professionnels. Génération de contenu, assistance au code, automatisation de tâches : leur potentiel est immense. Mais leur …
Curevo Enrolls First Participants in Phase 2 Extension Trial
GlobeNewswire
·
June 2, 2025
SEATTLE, June 02, 2025 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability, today announces the enrollment of the first …
RBC iShares élargit son offre de produits iShares Core grâce au lancement de nouveaux FNB
GlobeNewswire
·
June 2, 2025
TORONTO, 02 juin 2025 (GLOBE NEWSWIRE) -- Aujourd’hui, RBC iShares élargit sa gamme de fonds négociés en bourse (« FNB ») iShares Core avec le lancement de deux FNB iShares (individuellement et collectivement, un ou les « Fonds iShares »). Le iShares Core …
RBC iShares Expands iShares Core Offering with Launch of New ETFs
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Today, RBC iShares expands its iShares Core exchange traded fund (ETF) lineup with the launch of two iShares ETFs (each an ‘iShares Fund’ and collectively, the ‘iShares Funds’). The iShares Core S…
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
GlobeNewswire
·
June 2, 2025
Strategic combination establishes a market-leading mental health company with a pipeline that includes potentially transformative, rapid-acting psychedelic assets differentiated by their convenient route of administration and short time-in-clinic Combined …
Life360 Proposes Convertible Senior Notes Offering
GlobeNewswire
·
June 2, 2025
SAN FRANCISCO, June 02, 2025 (GLOBE NEWSWIRE) -- Life360, Inc. (“Life360” or the “Company”) (NASDAQ: LIF, ASX: 360), today announced its intention to offer, subject to market and other conditions, $250 million aggregate principal amount of convertible …
ThermAI Announces Investment from Flux and Zelcore Co-Founder Daniel Keller
GlobeNewswire
·
June 2, 2025
LONDON, June 02, 2025 (GLOBE NEWSWIRE) -- ThermAI, the innovative decentralised compute and heat-recovery protocol, has announced a strategic investment from Daniel Keller, Co-Founder of Flux and the lead architect behind Zelcore. Keller’s backing will …